Detailed price information for Avidity Biosciences Inc (RNA-Q) from The Globe and Mail including charting and trades.

Bristol-Myers Squibb Company (NYSE: BMY) is one of the stocks Jim Cramer recently shed light on. When a caller noted that the ...

The report, from 340B Health, claims that changes proposed by major drugmakers to replace upfront discounts with post-sale rebates for outpatient drugs would hit safety-net hospitals with significant ...

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...

Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...

Gilead Sciences generates stellar profit margins with its HIV and hepatitis C virus, or HCV, portfolio, which requires only a small salesforce and inexpensive manufacturing. We think its portfolio and ...

Treatment with adagrasib (Krazati) significantly improved progression-free-survival (PFS) in previously treated patients with ...

Covenant Health is now offering CAR T-cell therapy at the Joe Arrington Cancer Research & Treatment Center, marking a major advancement in personalized cancer treatment in West Texas.

Key Points Prime Medicine posted GAAP revenue of $1.1 million, missing analyst expectations by over 70% (GAAP). Reported net loss (GAAP) narrowed to $52.6 million, driven by reduced research and ...

Some high-profile healthcare names are at even cheaper valuations. For example, Merck is trading at a forward P/E of 8.7, ...

Emma Charles shares her vision for healthcare, how AI is reshaping pharma and why access to innovation must be faster and ...